Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
14.66B | 13.19B | 11.88B | 12.57B | 11.34B | Gross Profit |
3.84B | 2.65B | 2.16B | 2.67B | 2.07B | EBIT |
1.82B | 681.00M | 207.00M | 745.00M | 353.21M | EBITDA |
2.21B | 1.33B | 1.36B | 1.58B | 946.43M | Net Income Common Stockholders |
1.38B | 583.00M | 669.00M | 757.00M | 333.76M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.02B | 5.32B | 6.43B | 4.47B | 4.18B | Total Assets |
27.47B | 27.22B | 28.67B | 24.98B | 25.19B | Total Debt |
3.55B | 4.87B | 6.75B | 2.84B | 4.09B | Net Debt |
-2.47B | -450.00M | 322.00M | -1.63B | -88.33M | Total Liabilities |
6.40B | 7.33B | 9.12B | 5.64B | 6.39B | Stockholders Equity |
21.07B | 19.89B | 19.55B | 19.34B | 18.80B |
Cash Flow | Free Cash Flow | |||
2.61B | 87.00M | -1.92B | 2.01B | 1.76B | Operating Cash Flow |
3.06B | 767.00M | -908.00M | 2.38B | 1.92B | Investing Cash Flow |
-763.00M | 76.00M | -328.00M | -959.00M | 212.21M | Financing Cash Flow |
-1.53B | -2.20B | 3.40B | -1.38B | -1.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥6.93B | 11.78 | 2.64% | 6.93% | -6.22% | ||
77 Outperform | ¥10.77B | 9.23 | 6.33% | 6.57% | 32.45% | ||
75 Outperform | ¥4.97B | 11.46 | 1.51% | 2.02% | 5.55% | ||
66 Neutral | ¥8.38B | 5.41 | 1.47% | 11.14% | 148.26% | ||
66 Neutral | ¥6.47B | 8.96 | 3.52% | 0.26% | 80.37% | ||
60 Neutral | ¥7.01B | 13.43 | 1.59% | -0.49% | 137.27% | ||
51 Neutral | $2.01B | -1.27 | -21.11% | 5.15% | 2.92% | -30.46% |